In fact, osteoporosis is at least four times more prevalent in PBC patients compared to age- or gender-matched controls.60 The positive role of FXR in osteogenesis prompted us to explore its potential therapeutic applications in osteoporosis. The gene discussed is NR1H4; the disease is primary biliary cholangitis.